HLscience Co Ltd
239610
Company Profile
Business description
HLscience Co Ltd is a technology platform company focused on research into new bio-healthcare materials and technologies. It operates a CDMO business for individually approved raw materials from the Ministry of Food and Drug Safety (MFDS), research and development of newly approved raw materials and natural products based on its own proprietary technology, research and development of inner beauty and pharmaceutical cosmetics, microbiome business, health functional foods, quasi-drugs, and health-oriented foods.
Contact
36 Dongsanjae-gil
Bongdam-eup
Gyeonggi-do
Hwaseong-si
KORT: +82 314219903
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
84
Stocks News & Analysis
stocks
Is this still an ASX share to own forever?
Find out how this defensive player has fared after earnings.
stocks
After earnings, is Nvidia stock a buy, a sell, or fairly valued?
No signs of a slowdown in demand for Nvidia’s chips, and the long-term picture looks bright.
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,091.40 | 51.20 | 0.57% |
| CAC 40 | 7,698.92 | 20.79 | -0.27% |
| DAX 40 | 23,770.33 | 175.53 | 0.74% |
| Dow JONES (US) | 45,593.25 | 322.02 | 0.71% |
| FTSE 100 | 9,216.87 | 38.88 | 0.42% |
| HKSE | 25,058.51 | 284.92 | -1.12% |
| NASDAQ | 21,655.50 | 157.77 | 0.73% |
| Nikkei 225 | 42,580.27 | 641.38 | 1.53% |
| NZX 50 Index | 13,133.20 | 58.39 | 0.45% |
| S&P 500 | 6,490.60 | 42.34 | 0.66% |
| S&P/ASX 200 | 8,826.50 | 59.20 | 0.68% |
| SSE Composite Index | 3,765.88 | 47.68 | -1.25% |